DE602004003582D1 - Akapsuläre i p. multocida hyae /i deletionsmutanten - Google Patents

Akapsuläre i p. multocida hyae /i deletionsmutanten

Info

Publication number
DE602004003582D1
DE602004003582D1 DE602004003582T DE602004003582T DE602004003582D1 DE 602004003582 D1 DE602004003582 D1 DE 602004003582D1 DE 602004003582 T DE602004003582 T DE 602004003582T DE 602004003582 T DE602004003582 T DE 602004003582T DE 602004003582 D1 DE602004003582 D1 DE 602004003582D1
Authority
DE
Germany
Prior art keywords
multocida
deletion mutants
akapsular
hyae
birds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004003582T
Other languages
English (en)
Other versions
DE602004003582T2 (de
Inventor
E Briggs
M Tatum
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotechnology Research and Development Corp
US Department of Agriculture USDA
Original Assignee
Biotechnology Research and Development Corp
US Department of Agriculture USDA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotechnology Research and Development Corp, US Department of Agriculture USDA filed Critical Biotechnology Research and Development Corp
Publication of DE602004003582D1 publication Critical patent/DE602004003582D1/de
Application granted granted Critical
Publication of DE602004003582T2 publication Critical patent/DE602004003582T2/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
DE602004003582T 2003-07-02 2004-07-02 Akapsuläre i p. multocida hyae deletionsmutanten Active DE602004003582T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60893103P 2003-07-02 2003-07-02
US608931P 2003-07-02
PCT/US2004/021274 WO2005003330A2 (en) 2003-07-02 2004-07-02 Acapsular p. multocida hyae deletion mutants

Publications (2)

Publication Number Publication Date
DE602004003582D1 true DE602004003582D1 (de) 2007-01-18
DE602004003582T2 DE602004003582T2 (de) 2007-09-20

Family

ID=33564219

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004003582T Active DE602004003582T2 (de) 2003-07-02 2004-07-02 Akapsuläre i p. multocida hyae deletionsmutanten

Country Status (20)

Country Link
US (1) US7351416B2 (de)
EP (1) EP1638598B1 (de)
JP (2) JP5001647B2 (de)
KR (1) KR101119216B1 (de)
CN (1) CN1798574B (de)
AT (1) ATE347373T1 (de)
AU (1) AU2004254619B2 (de)
BR (1) BRPI0410911B1 (de)
CA (1) CA2530779C (de)
DE (1) DE602004003582T2 (de)
DK (1) DK1638598T3 (de)
ES (1) ES2278344T3 (de)
HK (1) HK1088561A1 (de)
HR (1) HRP20070084T3 (de)
NZ (1) NZ543771A (de)
PL (1) PL1638598T3 (de)
PT (1) PT1638598E (de)
SI (1) SI1638598T1 (de)
WO (1) WO2005003330A2 (de)
ZA (1) ZA200509533B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080241192A1 (en) * 2007-03-26 2008-10-02 Wyeth Vaccination against multiple serotypes of pasteurella multocida
JP5808671B2 (ja) * 2008-11-10 2015-11-10 ノヴォ ノルディスク アー／エス 機能グループｉｉ莢膜遺伝子クラスターを有しないｅ．ｃｏｌｉｂｌ２１株
US9115547B2 (en) * 2009-06-22 2015-08-25 Frank's International, Llc Large diameter tubular lifting apparatuses and methods
WO2010149190A1 (en) 2009-06-26 2010-12-29 Max-Planck-Gesellschaft Zur Novel fluorinated rhodamines as photostable fluorescent dyes for labelling and imaging techniques
US9314519B2 (en) 2012-08-21 2016-04-19 Intervet Inc. Liquid stable virus vaccines
EP3384927B1 (de) 2012-11-08 2022-07-06 Boehringer Ingelheim Animal Health USA Inc. Attenuierte mannheimia-haemolytica-impfstoffe sowie verfahren zur herstellung und verwendung
US20140147475A1 (en) 2012-11-29 2014-05-29 Antonius Arnoldus Christiaan Jacobs Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida
US9393298B2 (en) 2013-03-15 2016-07-19 Intervet Inc. Liquid stable bovine virus vaccines
US9480739B2 (en) 2013-03-15 2016-11-01 Intervet Inc. Bovine virus vaccines that are liquid stable
AU2014234452B2 (en) 2013-03-18 2018-02-22 Intervet International B.V. Vaccine to protect a ruminant against pneumonia caused by Mannheimia haemolytica
AR097762A1 (es) 2013-09-27 2016-04-13 Intervet Int Bv Formulaciones secas de vacunas que son estables a temperatura ambiente
ES2824402T3 (es) 2013-11-01 2021-05-12 Boehringer Ingelheim Animal Health Usa Inc Vacunas atenuadas contra Pasteurella multocida y procedimientos de fabricación y uso de las mismas
AR099470A1 (es) 2014-02-17 2016-07-27 Intervet Int Bv Vacunas de virus de aves de corral líquidas
TWI670085B (zh) 2014-02-19 2019-09-01 荷蘭商英特威國際公司 液體穩定之豬病毒疫苗
EP3188750B1 (de) 2014-09-03 2020-03-11 Intervet International B.V. Attenuiertes bovines coronavirus und verwandte impfstoffe

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL52815A (en) * 1977-08-24 1983-03-31 Israel State Fowl cholera vaccine and process for producing an attenuated non-virulent strain of pasteurella multocida
US6086894A (en) * 1996-06-27 2000-07-11 Virginia Tech Intellectual Properties, Inc. Recombinant vaccine for diseases caused by encapsulated organisms
US20010018055A1 (en) * 1997-09-25 2001-08-30 Briggs Robert E. Deletion mutants of virulence factors of pasteurellaceae
IL158007A0 (en) * 2001-03-23 2004-03-28 S2 Technologies Inc Development and testing system and method
US20040029129A1 (en) * 2001-10-25 2004-02-12 Liangsu Wang Identification of essential genes in microorganisms
US7449178B2 (en) * 2002-04-05 2008-11-11 Merial Limited Attenuated gram negative bacteria
ES2346915T3 (es) * 2002-04-05 2010-10-21 Merial Bacterias gram negativas atenuadas.

Also Published As

Publication number Publication date
DK1638598T3 (da) 2007-03-26
KR101119216B1 (ko) 2013-03-18
ATE347373T1 (de) 2006-12-15
US7351416B2 (en) 2008-04-01
JP2011024587A (ja) 2011-02-10
HK1088561A1 (en) 2006-12-08
CA2530779A1 (en) 2005-01-13
CA2530779C (en) 2012-06-05
CN1798574B (zh) 2013-12-11
DE602004003582T2 (de) 2007-09-20
US20050106185A1 (en) 2005-05-19
KR20060020657A (ko) 2006-03-06
BRPI0410911A (pt) 2006-06-27
WO2005003330A3 (en) 2005-03-03
AU2004254619B2 (en) 2009-05-21
AU2004254619A1 (en) 2005-01-13
PL1638598T3 (pl) 2007-05-31
WO2005003330A2 (en) 2005-01-13
ES2278344T3 (es) 2007-08-01
NZ543771A (en) 2008-05-30
SI1638598T1 (sl) 2007-04-30
PT1638598E (pt) 2007-03-30
JP5649881B2 (ja) 2015-01-07
JP5001647B2 (ja) 2012-08-15
EP1638598A2 (de) 2006-03-29
BRPI0410911B1 (pt) 2014-07-08
HRP20070084T3 (en) 2008-09-30
CN1798574A (zh) 2006-07-05
JP2007524398A (ja) 2007-08-30
EP1638598B1 (de) 2006-12-06
ZA200509533B (en) 2007-03-28

Similar Documents

Publication Publication Date Title
HK1088561A1 (en) Acapsular i p. multocida hyae /I. deletion mutants
Bizikova et al. Role of genetics and the environment in the pathogenesis of canine atopic dermatitis
AR076613A1 (es) Alimento para mascotas en forma de alimento granulado recubierto
NO971051D0 (no) Middel for å öke produksjonen av oppdretts- og produksjonsdyr i fjærfeindustrien
DE60030253D1 (de) Antioxidative zusammensetzungen für haustiere
BRPI0520114A2 (pt) espaÇos de colaboraÇço
Murphy et al. Pig‐shed air polluted by α‐haemolytic cocci and ammonia causes subclinical disease and production losses
BRPI0510930A (pt) vacinas de subunidade de prrsv
NO20040354L (no) Fremgangsmater og sammensetninger for kontroll av koksidose
Torre et al. Four-component Staphylococcus aureus vaccine 4C-staph enhances Fcγ receptor expression in neutrophils and monocytes and mitigates S. aureus infection in neutropenic mice
NL189138B (nl) Stikstofbevattende samenstellingen met reinigende eigenschappen, hun toepassing als toevoegsels en brandstofsamenstellingen die hen bevatten.
ATE322503T1 (de) Gefrierschutzprotein
FI20021518A0 (fi) Avidiinin lämpökestävyyden lisääminen
PT1276763E (pt) Proteinas anti-congelantes sua producao e utilizacao
WO2003096799A3 (en) Multiple closed nucleus breeding for swine production
BRPI0506699A (pt) método para lavar aves domésticas durante o processamento com composições de ácido peroxicarboxìlicos de cadeias médias
RU2009101018A (ru) Индукция толерантности к белкам яиц
ATE377943T1 (de) Verfahren zur züchtung von nicht-menschliche säugertieren
BR0115310A (pt) Ração
BR9910227A (pt) Métodos de criação de animais para a produção de carne.
Pang et al. Induction of phenoloxidases in the humoral fluids of amphioxus Branchiostoma belcheri by Vibrio alginolyticus and Escherichia coli
SE9800505L (sv) Probiotisk komposition innehållande sporer från jästarten Endomyces fibuliger och användning därav
MXPA05009489A (es) Procedimientos para identificacion de atributos geneticos en animales.
ATE419393T1 (de) Polymorphismus des igf2-gens und verbesserte produktionseigenschaften von rindern
CN204426256U (zh) 可便于排泄物回收的圈养结构

Legal Events

Date Code Title Description
8364 No opposition during term of opposition